Risk Minimisation Materials

RoActemra Dosing Guide for RoActemra (tocilizumab) intravenous (IV) and subcutaneous (SC) formulations

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

For Healthcare Professionals